World-Class Deeley Research Centre
Located in Victoria, the Deeley Research Centre (DRC) is one of the first sites in the world to pioneer an immunotherapy research program that uses genomic approaches to generate more precise and potent immune responses against cancer.
Immunotherapy Clinical Trials
Deeley Research Centre Director Dr. Brad Nelson and his team are joining forces with experts at BC Cancer’s Genome Sciences Centre in Vancouver to deliver truly personalized immunotherapy to patients in B.C.
Adoptive T Cell Therapy (ACT) is one of the most promising forms of immunotherapy. ACT clinical trials have the potential to save the lives of British Columbians facing all types of cancer.